The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bezuglova L.V.

JSC «Vector-Best»

Isaeva O.V.

Russian Medical Academy of Continuous Professional Education;
Mechnikov Research Institute for Vaccines and Sera

Karlsen A.A.

Russian Medical Academy of Continuous Professional Education;
Mechnikov Research Institute for Vaccines and Sera

Ilchenko L.Y.

Mechnikov Research Institute for Vaccines and Sera;
Pirogov Russian National Research Medical University

Sleptsova S.S.

North-Eastern Federal University, Medical Institute

Saryglar A.A.

Kyzyl Infectious Hospital»

Poryvaeva V.A.

JSC «Vector-Best», Research and Production area

Mosina Ya.D.

JSC «Vector-Best», Research and Production area

Agafonova O.A.

JSC «Vector-Best», Research and Production area

Mogilnykh A.K.

JSC «Vector-Best», Research and Production area

Kyuregyan K.K.

Russian Medical Academy of Continuous Professional Education;
Mechnikov Research Institute for Vaccines and Sera

Mikhailov M.I.

Russian Medical Academy of Continuous Professional Education;
Mechnikov Research Institute for Vaccines and Sera

Netesov S.V.

Novosibirsk State University

Netesova I.G.

JSC «Vector-Best»

Hepatitis B virus genotypes in patients with hepatitis D, determined by the panel of own development monoclonal antibodies

Authors:

Bezuglova L.V., Isaeva O.V., Karlsen A.A., Ilchenko L.Y., Sleptsova S.S., Saryglar A.A., Poryvaeva V.A., Mosina Ya.D., Agafonova O.A., Mogilnykh A.K., Kyuregyan K.K., Mikhailov M.I., Netesov S.V., Netesova I.G.

More about the authors

Views: 2515

Downloaded: 29


To cite this article:

Bezuglova LV, Isaeva OV, Karlsen AA, et al. . Hepatitis B virus genotypes in patients with hepatitis D, determined by the panel of own development monoclonal antibodies. Molecular Genetics, Microbiology and Virology. 2022;40(2):43‑50. (In Russ.)
https://doi.org/10.17116/molgen20224002143

Recommended articles:
Modern pathogenetic treatment of rare demye­linating diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):33-36

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.